Ian Anderson
Director - Analytical Sciences Technology & Manufacturing Science & Technology Orchard Therapeutics
Seminars
Wednesday 6th May 2026
Panel Discussion: What Does a ‘Good Enough’ Potency Assay Panel Look Like?
9:00 am
- Exploring why some teams still run ddPCR, ELISA, AUC, HPLC and TEM and how to reduce redundancy
- Discussing opportunities for how early teams can converge on a smaller assay panel
- Is there a one-size-fits-all, and how close are we to establishing one?
Wednesday 6th May 2026
How to Design & Validate Potency Assays for Hard-to-Transduce Serotypes & Tissue-Specific Promoters Against Real-World Constraints
11:45 am
- Designing functional potency assays that reflect true mode of action, using enzyme-based or activity-driven endpoints embedded within cell-based systems
- Implementing layered control strategies to manage variability across complex cell-based potency assays to enable qualification, validation, and long-term assay stability
- Reviewing strategies for managing assay life cycle
